You are here
Visiongain Report Provides Critical Market-led Data on the $68bn Gastrointestinal Therapeutics Market
- Top 50 Gastrointestinal Therapeutic Companies 2020
- GlaxoSmithKline, Abbott, Allergan, Eli Lilly, Evoke Pharma, Other Companies
LONDON, Nov. 21, 2019 /PRNewswire/ -- The gastrointestinal (GI) therapeutics industry is on the rise; growing to reach $68,237.0m by 2028. This growth stems from rising prevalence of GI disorders. Moreover, the increase in R&D has been a priority of the big pharma companies to infuse the drug pipelines with a new set of candidates with a high potential of reaching the clinical stage. However, the pricing pressure due to rising competition has hampered the market growth. On the contrary, the expiry of high-profile patents, which will carve the path for the launch of generic drugs in the market can provide growth opportunities to the other players in the market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 263-page report you will receive 116 charts– all unavailable elsewhere.
The 263-page Visiongain report provides clear detailed insight into the leading 50 gastrointestinal therapeutic companies. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
To request sample pages from this report please contact Sara Peerun at email@example.com or refer to our website: https://www.visiongain.com/report/top-50-gastrointestinal-therapeutic-companies-2020/#download_sampe_div
• Our study discusses the selected leading companies that are the major players in the gastrointestinal drugs market:
• Alexion Pharmaceuticals
• ANI Pharmaceuticals, Inc.
• Bayer AG
• Eisai Co., Ltd.
• Eli Lilly
• Evoke Pharma
• Intercept Pharmaceuticals
• Ironwood Pharmaceuticals
• Janssen Pharmaceutica
• Kyowa Hakko Kirin Co. Ltd.
• Mallinckrodt plc
• Synergy Pharmaceuticals Inc.
• Cadila Healthcare Ltd.
• Novartis AG
• Merck & Co., Inc.
• Lexicon Pharmaceuticals, Inc.
• ETX Pharma, Inc.
• Theravance Biopharma, Inc.
• Other companies
• This report also discusses factors that drive and restrain the market, as well as opportunities in the gastrointestinal therapeutic market.
To request a report overview of this report please contact Sara Peerun at firstname.lastname@example.org or refer to our website: https://www.visiongain.com/report/top-50-gastrointestinal-therapeutic-companies-2020/
Did you know that we also offer a report add-on service? Email email@example.com to discuss any customized research needs you may have.
Companies covered in the report include:
Advanced Accelerator Applications
Alexion Pharmaceuticals Inc.
Altos Therapeutics LLC
ANI Pharmaceuticals, Inc.
Array BioPharma Inc.
Astellas Pharma, Inc.
AzurRx BioPharma, Inc.
Bausch Health Companies Inc.
Bayer HealthCare Pharmaceuticals
Boehringer Ingelheim International GmbH
Cadila Healthcare Ltd.
Daiichi Sankyo, Inc.
EA Pharma Co., Ltd.
Eisai Co., Ltd.
ETX Pharma, Inc.
Evoke Pharma, Inc.
Food and Drug Administration (FDA)
Forest Laboratories, LLC
Furiex Pharmaceuticals, Inc.
Gilead Sciences, Inc.
ICR (The Institute of Cancer Research)
Intercept Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc.
Johnson & Johnson
Kyowa Hakko Kirin Co. Ltd.
Lexicon Pharmaceuticals, Inc.
Lonza Group AG
Mitsubishi Tanabe Pharma Corporation
Mochida Pharmaceutical Co., Ltd.
Oncolytics Biotech, Inc.
Ono Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
PvP Biologics, Inc.
RedHill Biopharma Ltd.
Rhythm Health, Inc.
St. Jude Medical, Inc.
Sucampo Pharmaceuticals, Inc.
Synergy Pharmaceuticals, Inc.
Theravance Biopharma, Inc.
Universal Cells, Inc.
Zeria Pharmaceutical Co., Ltd.
To see a report overview please e-mail Sara Peerun on firstname.lastname@example.org